Cargando…

A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics

Coronavirus disease (COVID-19) rapidly expands to a global pandemic and its impact on public health varies from country to country. It is caused by a new virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is imperative for relapsing current antiviral therapeutics owing to randomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prathiviraj, R., Saranya, S., Bharathi, M., Chellapandi, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935700/ https://www.ncbi.nlm.nih.gov/pubmed/33705994 http://dx.doi.org/10.1016/j.compbiomed.2021.104315

Ejemplares similares

Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates
por: Prathiviraj, Ragothaman, et al.
Publicado: (2022)

Methanobacterium formicicum as a target rumen methanogen for the development of new methane mitigation interventions: A review
por: Chellapandi, P, et al.
Publicado: (2018)

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
por: Chellapandi, P., et al.
Publicado: (2020)

Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2
por: Prathiviraj, R., et al.
Publicado: (2020)

Hijacking of host mitochondria by Toxoplasma gondii and SARS-CoV-2
por: Zhang, Ruize, et al.
Publicado: (2022)

Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage
por: Yu, Changqing, et al.
Publicado: (2023)

SARS-CoV-2 hijacks host cell genome instability pathways
por: Victor, Joshua, et al.
Publicado: (2022)

SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication
por: Zhang, Yuchen, et al.
Publicado: (2021)

Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2
por: Xu, Gang, et al.
Publicado: (2022)

Mitochondrial hijacking: A potential mechanism for SARS-CoV-2 to impair female fertility
por: Sun, Jun, et al.
Publicado: (2022)

SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection
por: Garvanska, Dimitriya H., et al.
Publicado: (2023)

SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response
por: Guo, Guijie, et al.
Publicado: (2021)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis
por: Guo, Saisai, et al.
Publicado: (2022)

SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication
por: Higgins, Christina A., et al.
Publicado: (2023)

SARS‐CoV‐2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms
por: O’Donoghue, Seán I, et al.
Publicado: (2021)

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
por: Nchioua, Rayhane, et al.
Publicado: (2022)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy
por: Marcink, T. C., et al.
Publicado: (2020)

Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets
por: Li, Jiaqi, et al.
Publicado: (2023)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review
por: Gil Martínez, Victoria, et al.
Publicado: (2021)

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
por: Hall, Matthew D, et al.
Publicado: (2021)

Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses
por: Luquain-Costaz, Céline, et al.
Publicado: (2020)

How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System
por: Sajidah, Elma Sakinatus, et al.
Publicado: (2021)

SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters(1)
por: Zhou, Biao, et al.
Publicado: (2023)

Comparative analysis of differential proteome-wide protein-protein interaction network of Methanobrevibacter ruminantium M1
por: M, Bharathi, et al.
Publicado: (2019)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
por: Miorin, Lisa, et al.
Publicado: (2020)

SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike–mediated cell-to-cell fusion
por: Zhang, Yu-Yuan, et al.
Publicado: (2022)

A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
por: Rubattu, Speranza, et al.
Publicado: (2021)

The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates
por: Azad, Gajendra Kumar
Publicado: (2021)

Characterizing genomic variants and mutations in SARS-CoV-2 proteins from Indian isolates
por: Das, Jayanta Kumar, et al.
Publicado: (2021)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
por: Rebeaud, Mathieu E., et al.
Publicado: (2020)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vl5al889nath11t40d9h3rvvcp